NCT02106988View on ClinicalTrials.gov

Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 16, 2015

Primary Completion Date

January 31, 2034

Study Completion Date

January 31, 2034

Conditions
Lymphoma
Interventions
RADIATION

Radiation Therapy

Radiation therapy delivered for a total dose of 50.4 to 54 Gy 5 days a week for 28 to 30 treatments.

DRUG

Dexamethasone

40 mg by vein Days 1-3 in a 21 day cycle.

DRUG

Etoposide phosphate

67 mg/m2 by vein on Days 1-3 of a 21 day cycle.

DRUG

Ifosfamide

1 g/m2 by vein on Days 1-3 of a 21 day cycle.

DRUG

Mesna

0.4 g/m2 by vein on Days 1-3 with Ifosfamide, 0.6 g/m2 by vein over 24 hours daily on Days 1-3 via ambulatory pump.

DRUG

Carboplatin

200 mg/m2 by vein on Day 1 of a 21 day cycle.

Trial Locations (1)

77030

RECRUITING

MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER